All Cosmos Bio-Tech Holding Corporation (4148.TW)

TWD 45.55

(-1.83%)

EBITDA Summary of All Cosmos Bio-Tech Holding Corporation

All Cosmos Bio-Tech Holding Corporation's latest annual EBITDA in 2023 was 305.41 Million TWD , down -65.58% from previous year.
All Cosmos Bio-Tech Holding Corporation's latest quarterly EBITDA in 2024 Q2 was 5.28 Million TWD , down -43.18% from previous quarter.
All Cosmos Bio-Tech Holding Corporation reported an annual EBITDA of 699.84 Million TWD in 2022, up 121.04% from previous year.
All Cosmos Bio-Tech Holding Corporation reported an annual EBITDA of 373.02 Million TWD in 2021, up 59.79% from previous year.
All Cosmos Bio-Tech Holding Corporation reported a quarterly EBITDA of 36.12 Million TWD for 2024 Q1, up 90.78% from previous quarter.
All Cosmos Bio-Tech Holding Corporation reported a quarterly EBITDA of 135.36 Million TWD for 2023 Q3, up 191.98% from previous quarter.

Annual EBITDA Chart of All Cosmos Bio-Tech Holding Corporation (2023 - 2011)

Historical Annual EBITDA of All Cosmos Bio-Tech Holding Corporation (2023 - 2011)

Year	EBITDA	EBITDA Growth
2023	305.41 Million TWD	-65.58%
2022	699.84 Million TWD	121.04%
2021	373.02 Million TWD	59.79%
2020	205.56 Million TWD	-7.97%
2019	166.66 Million TWD	-56.39%
2018	463.91 Million TWD	6.21%
2017	461.29 Million TWD	12.85%
2016	408.75 Million TWD	23.25%
2015	296.51 Million TWD	46.42%
2014	255.03 Million TWD	23.92%
2013	199.58 Million TWD	-25.98%
2012	247.34 Million TWD	-16.48%
2011	193.03 Million TWD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	5.28 Million TWD	-43.18%
2024 Q1	36.12 Million TWD	90.78%
2023 Q3	135.36 Million TWD	191.98%
2023 Q2	46.36 Million TWD	-50.43%
2023 Q1	93.52 Million TWD	-8.81%
2023 FY	- TWD	-65.58%
2023 Q4	52.35 Million TWD	-61.32%
2022 Q1	138.59 Million TWD	11.19%
2022 FY	- TWD	121.04%
2022 Q4	102.55 Million TWD	-64.76%
2022 Q2	162.34 Million TWD	17.13%
2022 Q3	291.02 Million TWD	79.27%
2021 Q3	81.8 Million TWD	5.15%
2021 Q4	124.65 Million TWD	52.37%
2021 FY	- TWD	59.79%
2021 Q2	77.8 Million TWD	159.8%
2021 Q1	29.94 Million TWD	-45.83%
2020 Q3	58.13 Million TWD	-35.17%
2020 Q4	55.28 Million TWD	-4.91%
2020 Q1	-6.46 Million TWD	-117.93%
2020 FY	- TWD	-7.97%
2020 Q2	89.67 Million TWD	1487.96%
2019 Q3	59.87 Million TWD	-42.19%
2019 Q4	36.03 Million TWD	-39.81%
2019 FY	- TWD	-56.39%
2019 Q1	14.18 Million TWD	-77.8%
2019 Q2	103.57 Million TWD	630.11%
2018 Q2	172.47 Million TWD	64.23%
2018 FY	- TWD	6.21%
2018 Q4	63.9 Million TWD	-56.98%
2018 Q3	148.53 Million TWD	-13.88%
2018 Q1	105.02 Million TWD	22.89%
2017 Q3	135.61 Million TWD	5.52%
2017 Q2	128.52 Million TWD	15.07%
2017 Q1	111.69 Million TWD	18.15%
2017 FY	- TWD	12.85%
2017 Q4	85.45 Million TWD	-36.99%
2016 Q2	102.17 Million TWD	16.66%
2016 Q3	115.54 Million TWD	13.09%
2016 Q4	94.53 Million TWD	-18.18%
2016 Q1	87.57 Million TWD	-14.8%
2016 FY	- TWD	23.25%
2015 FY	- TWD	46.42%
2015 Q2	105.08 Million TWD	341.61%
2015 Q4	102.79 Million TWD	32.23%
2015 Q3	77.73 Million TWD	-26.03%
2015 Q1	23.79 Million TWD	0.0%
2014 FY	- TWD	23.92%
2013 FY	- TWD	-25.98%
2013 Q1	48.85 Million TWD	-35.45%
2012 FY	- TWD	-16.48%
2012 Q4	75.69 Million TWD	0.0%
2011 FY	- TWD	0.0%

Peer EBITDA Comparison of All Cosmos Bio-Tech Holding Corporation

Name	EBITDA	EBITDA Difference
Sinon Corporation	2.07 Billion TWD	85.302%
Taiwan Fertilizer Co., Ltd.	3.87 Billion TWD	92.127%
CH Biotech R&D Co., Ltd.	761.55 Million TWD	59.896%